These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 23518378)
1. Viability by MRI or PET would not have changed the results of the STICH trial. Asrani NS; Chareonthaitawee P; Pellikka PA Prog Cardiovasc Dis; 2013; 55(5):494-7. PubMed ID: 23518378 [TBL] [Abstract][Full Text] [Related]
2. Viability by MRI or PET would have changed the results of the STICH trial. Srichai MB; Jaber WA Prog Cardiovasc Dis; 2013; 55(5):487-93. PubMed ID: 23518377 [TBL] [Abstract][Full Text] [Related]
3. The world post-STICH: is this a "Game Changer?" A non-invasive cardiologist's perspective-revascularization is the treatment of choice only in patients who fail medical therapy. Elamm C; Fang JC Prog Cardiovasc Dis; 2013; 55(5):466-9. PubMed ID: 23518373 [TBL] [Abstract][Full Text] [Related]
4. The world post STICH: is this a "Game Changer?" A surgeon's perspective--revascularization is still the treatment of choice. Daggubati R; Arumugham P; Ferguson TB Prog Cardiovasc Dis; 2013; 55(5):470-5. PubMed ID: 23518374 [TBL] [Abstract][Full Text] [Related]
5. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons. Ogawa M; Doi K; Fukumoto A; Yaku H Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):673-5. PubMed ID: 17670732 [TBL] [Abstract][Full Text] [Related]
6. Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction. Tajouri TH; Chareonthaitawee P Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):55-63. PubMed ID: 20014935 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography]. Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477 [TBL] [Abstract][Full Text] [Related]
8. Myocardial viability: whom, what, why, which, and how? Mc Ardle BA; Beanlands RS Can J Cardiol; 2013 Mar; 29(3):399-402. PubMed ID: 23439021 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in determination of myocardial ischemia and viability: comparison with positron emission tomography and single-photon emission computed tomography in a porcine model. Wang L; Zhu HY; Tian JM; Huang SD; Kong LS; Lu JP Acta Radiol; 2007 Jun; 48(5):500-7. PubMed ID: 17520425 [TBL] [Abstract][Full Text] [Related]
11. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET. Demirkol MO Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637 [TBL] [Abstract][Full Text] [Related]
12. Role of viability imaging in the post-STICH era. Shah BN; Senior R Curr Opin Cardiol; 2014 Mar; 29(2):145-51. PubMed ID: 24385081 [TBL] [Abstract][Full Text] [Related]
13. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. O'Meara E; Mielniczuk LM; Wells GA; deKemp RA; Klein R; Coyle D; Mc Ardle B; Paterson I; White JA; Arnold M; Friedrich MG; Larose E; Dick A; Chow B; Dennie C; Haddad H; Ruddy T; Ukkonen H; Wisenberg G; Cantin B; Pibarot P; Freeman M; Turcotte E; Connelly K; Clarke J; Williams K; Racine N; Garrard L; Tardif JC; DaSilva J; Knuuti J; Beanlands R; Trials; 2013 Jul; 14():218. PubMed ID: 23866673 [TBL] [Abstract][Full Text] [Related]
14. MRI assessment of myocardial viability: comparison with other imaging techniques. Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H Rays; 1999; 24(1):96-108. PubMed ID: 10358387 [TBL] [Abstract][Full Text] [Related]
15. MRI for the assessment of myocardial viability. Weinsaft JW; Klem I; Judd RM Cardiol Clin; 2007 Feb; 25(1):35-56, v. PubMed ID: 17478239 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging. Katikireddy CK; Mann N; Brown D; Van Tosh A; Stergiopoulos K Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):55-73. PubMed ID: 22149526 [TBL] [Abstract][Full Text] [Related]
17. Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Imaging-guided selection of patients with ischemic heart failure for high-risk revascularization improves identification of those with the highest clinical benefit. Mielniczuk LM; Beanlands RS Circ Cardiovasc Imaging; 2012 Mar; 5(2):262-70; discussion 270. PubMed ID: 22438424 [No Abstract] [Full Text] [Related]
18. The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era. Shah BN; Khattar RS; Senior R Eur Heart J; 2013 May; 34(18):1323-36. PubMed ID: 23420867 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Kwong RY; Korlakunta H Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157 [TBL] [Abstract][Full Text] [Related]
20. Is there a need to assess myocardial viability in patients presenting with heart failure? Gramze NL; Shah DJ Curr Opin Cardiol; 2016 Sep; 31(5):501-9. PubMed ID: 27467175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]